TIMM17A
gene geneOn this page
Also known as TIM17TIM17A
Summary
TIMM17A (translocase of inner mitochondrial membrane 17A, HGNC:17315) is a protein-coding gene on chromosome 1q32.1, encoding Mitochondrial import inner membrane translocase subunit Tim17-A (Q99595). Essential component of the TIM23 complex, a complex that mediates the translocation of transit peptide-containing proteins across the mitochondrial inner membrane. It is a selective cancer dependency (DepMap: 18.5% of cell lines).
Predicted to contribute to protein transmembrane transporter activity. Predicted to be involved in protein import into mitochondrial matrix. Located in mitochondrial inner membrane and nucleoplasm. Part of TIM23 mitochondrial import inner membrane translocase complex.
Source: NCBI Gene 10440 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 35 total
- Cancer dependency (DepMap): dependent in 18.5% of screened cell lines
- MANE Select transcript:
NM_006335
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17315 |
| Approved symbol | TIMM17A |
| Name | translocase of inner mitochondrial membrane 17A |
| Location | 1q32.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TIM17, TIM17A |
| Ensembl gene | ENSG00000134375 |
| Ensembl biotype | protein_coding |
| OMIM | 605057 |
| Entrez | 10440 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 6 protein_coding, 3 protein_coding_CDS_not_defined
ENST00000367287, ENST00000478378, ENST00000482943, ENST00000484647, ENST00000880520, ENST00000880521, ENST00000880522, ENST00000934114, ENST00000955674
RefSeq mRNA: 1 — MANE Select: NM_006335
NM_006335
CCDS: CCDS1417
Canonical transcript exons
ENST00000367287 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001444069 | 201969469 | 201970664 |
| ENSE00001444070 | 201955503 | 201955552 |
| ENSE00003492217 | 201963616 | 201963744 |
| ENSE00003535049 | 201957511 | 201957574 |
| ENSE00003560786 | 201965433 | 201965543 |
| ENSE00003592824 | 201957281 | 201957380 |
Expression profiles
Bgee: expression breadth ubiquitous, 293 present calls, max score 98.39.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 55.9349 / max 1617.6651, expressed in 1821 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 7769 | 55.9349 | 1821 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| Brodmann (1909) area 23 | UBERON:0013554 | 98.39 | gold quality |
| heart right ventricle | UBERON:0002080 | 98.35 | gold quality |
| biceps brachii | UBERON:0001507 | 98.20 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 98.15 | gold quality |
| endothelial cell | CL:0000115 | 98.14 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 97.96 | gold quality |
| amniotic fluid | UBERON:0000173 | 97.78 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 97.72 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 97.70 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 97.66 | gold quality |
| nephron tubule | UBERON:0001231 | 97.46 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 97.45 | gold quality |
| parietal pleura | UBERON:0002400 | 97.42 | gold quality |
| myocardium | UBERON:0002349 | 97.40 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 97.32 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 97.29 | gold quality |
| pleura | UBERON:0000977 | 97.20 | gold quality |
| visceral pleura | UBERON:0002401 | 97.14 | gold quality |
| pons | UBERON:0000988 | 97.12 | gold quality |
| vastus lateralis | UBERON:0001379 | 97.07 | gold quality |
| oocyte | CL:0000023 | 97.04 | gold quality |
| diaphragm | UBERON:0001103 | 96.98 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 96.92 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 96.90 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 96.89 | gold quality |
| renal glomerulus | UBERON:0000074 | 96.86 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 96.80 | gold quality |
| secondary oocyte | CL:0000655 | 96.79 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 96.77 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 96.73 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
68 targeting TIMM17A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-302A-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302B-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302C-3P | 99.89 | 71.20 | 1778 |
| HSA-MIR-302D-3P | 99.89 | 71.25 | 1777 |
| HSA-MIR-6079 | 99.84 | 68.54 | 1170 |
| HSA-MIR-373-3P | 99.84 | 70.68 | 1668 |
| HSA-MIR-520E-3P | 99.84 | 70.55 | 1698 |
| HSA-MIR-372-3P | 99.83 | 70.58 | 1691 |
| HSA-MIR-520A-3P | 99.83 | 70.59 | 1687 |
| HSA-MIR-520B-3P | 99.83 | 70.56 | 1699 |
| HSA-MIR-520C-3P | 99.83 | 70.56 | 1699 |
| HSA-MIR-520D-3P | 99.83 | 70.78 | 1676 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-205-5P | 99.81 | 70.05 | 1557 |
| HSA-MIR-498-5P | 99.76 | 69.64 | 1807 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-1825 | 99.72 | 68.11 | 1089 |
| HSA-MIR-1208 | 99.70 | 68.28 | 1533 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 18.5% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 8)
- Tim17 is a conserved suppressor of mtDNA instability. (PMID:18826960)
- mRNA expression analysis and immunohistochemistry analysis in breast cancer tissues indicated that expression level of TIMM17A was directly correlated with tumor progression; survival analysis suggested TIMM17A was a prognosis factor in breast cancer. (PMID:20198662)
- High TIMM17A expression is associated with adverse pathological outcomes in breast cancer. (PMID:20972741)
- TIMM17A has a profound impact on the cellular function of breast cancer cells. A decrease of TIMM17A expression is associated with the reduction of the aggressiveness of breast cancer cells. (PMID:26977020)
- We also confirmed that lncRNA NEAT1 was up-regulated in breast cancer and inhibited the expression of miR-133b, and identified the mitochondrial protein translocase of inner mitochondrial membrane 17 homolog A (TIMM17A) that serves as the target of miR-133b. (PMID:31344855)
- Tim17 Updates: A Comprehensive Review of an Ancient Mitochondrial Protein Translocator. (PMID:33297490)
- Central role of Tim17 in mitochondrial presequence protein translocation. (PMID:37527780)
- TIMM17A overexpression in lung adenocarcinoma and its association with prognosis. (PMID:38632467)
Cross-species orthologs
11 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | timm17a | ENSDARG00000029510 |
| mus_musculus | Timm17a | ENSMUSG00000062580 |
| rattus_norvegicus | Timm17a | ENSRNOG00000007040 |
| drosophila_melanogaster | Tim17b2 | FBGN0020371 |
| drosophila_melanogaster | CG1724 | FBGN0031164 |
| drosophila_melanogaster | Tim17a2 | FBGN0037307 |
| drosophila_melanogaster | Tim17b1 | FBGN0037310 |
| drosophila_melanogaster | Tim17a1 | FBGN0038018 |
| drosophila_melanogaster | Tim17b | FBGN0263977 |
| caenorhabditis_elegans | WBGENE00017069 | |
| caenorhabditis_elegans | WBGENE00017119 |
Paralogs (1): TIMM17B (ENSG00000126768)
Protein
Protein identifiers
Mitochondrial import inner membrane translocase subunit Tim17-A — Q99595 (reviewed: Q99595)
Alternative names: Inner membrane preprotein translocase Tim17a
All UniProt accessions (1): Q99595
UniProt curated annotations — full annotation on UniProt →
Function. Essential component of the TIM23 complex, a complex that mediates the translocation of transit peptide-containing proteins across the mitochondrial inner membrane.
Subunit / interactions. Component of the TIM23 complex at least composed of TIMM23, TIMM17 (TIMM17A or TIMM17B) and TIMM50. The complex interacts with the TIMM44 component of the PAM complex and with DNAJC15.
Subcellular location. Mitochondrion inner membrane.
Post-translational modifications. Degraded by YMEL1 downstream of the integrated stress response (ISR).
Similarity. Belongs to the Tim17/Tim22/Tim23 family.
RefSeq proteins (1): NP_006326* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005678 | Tim17 | Family |
Pfam: PF02466
UniProt features (8 total): transmembrane region 3, chain 1, region of interest 1, compositionally biased region 1, disulfide bond 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q99595-F1 | 79.87 | 0.60 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 9–78
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-1268020 | Mitochondrial protein import |
| R-HSA-9837999 | Mitochondrial protein degradation |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-9609507 | Protein localization |
MSigDB gene sets: 206 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN, MULLIGHAN_NPM1_SIGNATURE_3_UP, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, BASSO_B_LYMPHOCYTE_NETWORK, ENK_UV_RESPONSE_KERATINOCYTE_UP, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, DITTMER_PTHLH_TARGETS_UP, GOBP_PROTEIN_TARGETING, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, PUJANA_CHEK2_PCC_NETWORK, WEI_MYCN_TARGETS_WITH_E_BOX, GCM_RING1, OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP, GCM_DPF2
GO Biological Process (4): obsolete protein targeting to mitochondrion (GO:0006626), intracellular protein transport (GO:0006886), protein import into mitochondrial matrix (GO:0030150), protein transport (GO:0015031)
GO Molecular Function (1): transmembrane protein transporter activity (GO:0008320)
GO Cellular Component (5): nucleoplasm (GO:0005654), mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), TIM23 mitochondrial import inner membrane translocase complex (GO:0005744), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Protein localization | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular protein localization | 2 |
| cellular anatomical structure | 2 |
| protein transport | 1 |
| intracellular transport | 1 |
| protein transmembrane import into intracellular organelle | 1 |
| protein localization to mitochondrion | 1 |
| import into the mitochondrion | 1 |
| mitochondrial protein import pathway | 1 |
| transport | 1 |
| establishment of protein localization | 1 |
| macromolecule transmembrane transporter activity | 1 |
| protein transmembrane transport | 1 |
| protein transporter activity | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| inner mitochondrial membrane protein complex | 1 |
Protein interactions and networks
STRING
1678 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TIMM17A | TIMM50 | Q3ZCQ8 | 999 |
| TIMM17A | TIMM44 | O43615 | 997 |
| TIMM17A | TIMM23 | O14925 | 988 |
| TIMM17A | TIMM21 | Q9BVV7 | 983 |
| TIMM17A | DNAJC19 | Q96DA6 | 954 |
| TIMM17A | TOMM70 | O94826 | 944 |
| TIMM17A | TIMM10 | P62072 | 943 |
| TIMM17A | PAM16 | Q9Y3D7 | 932 |
| TIMM17A | OXA1L | Q15070 | 923 |
| TIMM17A | TOMM20 | Q15388 | 922 |
| TIMM17A | HSPA9 | P30036 | 893 |
| TIMM17A | GRPEL1 | Q9HAV7 | 875 |
| TIMM17A | TOMM22 | Q9NS69 | 872 |
| TIMM17A | TOMM40 | O96008 | 865 |
| TIMM17A | TIMM9 | Q9Y5J7 | 807 |
IntAct
21 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ALDH3B2 | ALDH3B1 | psi-mi:“MI:0914”(association) | 0.560 |
| TUBA1A | TIMM17A | psi-mi:“MI:0915”(physical association) | 0.370 |
| RIPK4 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| DNAJC15 | TIMM17B | psi-mi:“MI:0914”(association) | 0.350 |
| P2RX5 | NOP56 | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM223 | psi-mi:“MI:0914”(association) | 0.350 | |
| MAGEA8 | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| GLMP | RTL8C | psi-mi:“MI:0914”(association) | 0.350 |
| P2RX5 | TNPO2 | psi-mi:“MI:0914”(association) | 0.350 |
| KLK8 | MGST3 | psi-mi:“MI:0914”(association) | 0.350 |
| APLNR | TTI1 | psi-mi:“MI:0914”(association) | 0.350 |
| MAGEA8 | B4GALT5 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC30A3 | WWP2 | psi-mi:“MI:0914”(association) | 0.350 |
| KRAS | IGKV2D-24 | psi-mi:“MI:0914”(association) | 0.350 |
| AKT1 | TIMM17A | psi-mi:“MI:2364”(proximity) | 0.270 |
| BRAF | TIMM17A | psi-mi:“MI:2364”(proximity) | 0.270 |
| VHL | TIMM17A | psi-mi:“MI:0915”(physical association) | 0.000 |
| TIMM17A | ROMO1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TIMM17A | ELOVL5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TIMM17A | HAP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (24): TIMM17A (Affinity Capture-Western), TIMM17A (Affinity Capture-Western), TIMM17A (Affinity Capture-MS), TIMM17A (Affinity Capture-MS), ELOVL5 (Affinity Capture-MS), ROMO1 (Affinity Capture-MS), TIMM17A (Affinity Capture-RNA), TIMM17A (Affinity Capture-MS), TIMM17A (Affinity Capture-MS), TIMM17A (Affinity Capture-MS), TIMM17A (Affinity Capture-MS), TIMM17A (Affinity Capture-MS), TIMM17A (Affinity Capture-MS), TIMM17A (Affinity Capture-MS), TIMM17A (Affinity Capture-MS)
ESM2 similar proteins: A4IFL0, B2RZ37, F1MDB2, F1N5S9, O14925, O35092, O35093, O49636, O60830, O95563, P11024, P38718, P39515, P59670, Q00765, Q0VCK9, Q13423, Q29RM3, Q2HJE9, Q5BIN4, Q5BJS4, Q5M7K0, Q5R4Z3, Q5RDD0, Q5RE33, Q5SRD1, Q5U4U5, Q5XH94, Q5XIA8, Q60870, Q6GM44, Q6INU6, Q8IVP5, Q8L7H8, Q8N5G0, Q91VC9, Q91ZQ0, Q99595, Q9CQ85, Q9D023
Diamond homologs: O35092, O44477, O60830, P39515, P59670, P87130, Q2HJE9, Q2UAP8, Q54K35, Q5BIN4, Q6BZY4, Q6NKU9, Q94EH2, Q99595, Q9C1E8, Q9CQ85, Q9JKW1, Q9LN27, Q9LYG1, Q9SP35, Q9VGA2, Q9VN97, Q9VNA0, Q9Z0V7, Q9Z0V8, A0A1D8PI78, P0CR88, P0CR89, P87146, Q5M7K0, Q9NAQ9, Q6FT37, A1XJK0, A2RVP7, O48528, Q12328, Q54QM0, Q5U4U5, Q6BT35, Q6CRJ6
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| TIMM17A | “form complex” | “TIM23 complex” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
35 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1012 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:201957272:T:A | acceptor_gain | 1.0000 |
| 1:201957279:A:AG | acceptor_gain | 1.0000 |
| 1:201957280:G:GG | acceptor_gain | 1.0000 |
| 1:201957280:GC:G | acceptor_gain | 1.0000 |
| 1:201957280:GCC:G | acceptor_gain | 1.0000 |
| 1:201957280:GCCC:G | acceptor_gain | 1.0000 |
| 1:201957378:GTG:G | donor_gain | 1.0000 |
| 1:201957381:G:GG | donor_gain | 1.0000 |
| 1:201957503:T:A | acceptor_gain | 1.0000 |
| 1:201957507:ATAG:A | acceptor_gain | 1.0000 |
| 1:201957507:ATAGG:A | acceptor_gain | 1.0000 |
| 1:201957508:T:G | acceptor_gain | 1.0000 |
| 1:201957508:TAGGG:T | acceptor_gain | 1.0000 |
| 1:201957509:A:AG | acceptor_gain | 1.0000 |
| 1:201957509:AG:A | acceptor_gain | 1.0000 |
| 1:201957509:AGG:A | acceptor_gain | 1.0000 |
| 1:201957509:AGGGA:A | acceptor_gain | 1.0000 |
| 1:201957510:G:GT | acceptor_gain | 1.0000 |
| 1:201957510:GG:G | acceptor_gain | 1.0000 |
| 1:201957510:GGG:G | acceptor_gain | 1.0000 |
| 1:201957510:GGGA:G | acceptor_gain | 1.0000 |
| 1:201957510:GGGAG:G | acceptor_gain | 1.0000 |
| 1:201957571:GGAG:G | donor_gain | 1.0000 |
| 1:201957572:G:GT | donor_gain | 1.0000 |
| 1:201957572:GAG:G | donor_gain | 1.0000 |
| 1:201957573:AGG:A | donor_loss | 1.0000 |
| 1:201957574:GGTA:G | donor_loss | 1.0000 |
| 1:201957575:G:GA | donor_loss | 1.0000 |
| 1:201957575:G:GG | donor_gain | 1.0000 |
| 1:201957576:T:A | donor_loss | 1.0000 |
AlphaMissense
1091 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:201957300:G:C | D16H | 1.000 |
| 1:201957301:A:T | D16V | 1.000 |
| 1:201957307:G:A | G18D | 1.000 |
| 1:201957324:G:C | G24R | 1.000 |
| 1:201957324:G:T | G24C | 1.000 |
| 1:201957325:G:A | G24D | 1.000 |
| 1:201957334:G:A | G27D | 1.000 |
| 1:201957337:G:A | G28D | 1.000 |
| 1:201957572:G:A | G63E | 1.000 |
| 1:201963621:T:C | F66L | 1.000 |
| 1:201963622:T:C | F66S | 1.000 |
| 1:201963623:T:A | F66L | 1.000 |
| 1:201963623:T:G | F66L | 1.000 |
| 1:201963625:C:A | A67E | 1.000 |
| 1:201963630:T:A | W69R | 1.000 |
| 1:201963630:T:C | W69R | 1.000 |
| 1:201963632:G:C | W69C | 1.000 |
| 1:201963632:G:T | W69C | 1.000 |
| 1:201963633:G:A | G70R | 1.000 |
| 1:201963633:G:C | G70R | 1.000 |
| 1:201963634:G:A | G70E | 1.000 |
| 1:201963637:G:A | G71E | 1.000 |
| 1:201963642:T:A | F73I | 1.000 |
| 1:201963642:T:C | F73L | 1.000 |
| 1:201963643:T:C | F73S | 1.000 |
| 1:201963644:T:A | F73L | 1.000 |
| 1:201963644:T:G | F73L | 1.000 |
| 1:201963698:C:A | N91K | 1.000 |
| 1:201963698:C:G | N91K | 1.000 |
| 1:201963703:T:A | I93N | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000131923 (1:201953550 G>A,C), RS1000185883 (1:201960545 G>T), RS1000295142 (1:201966719 G>A), RS1000328603 (1:201964969 T>A), RS1000398304 (1:201964816 T>A,C), RS1000410873 (1:201966991 T>G), RS1000474564 (1:201953835 CCTTT>C), RS1000700812 (1:201955323 G>A), RS1000704869 (1:201960823 A>C), RS1000892267 (1:201960532 A>T), RS1001601470 (1:201963504 T>C), RS1001772832 (1:201958252 C>T), RS1002031034 (1:201960176 A>T), RS1002040538 (1:201966662 G>A,C), RS1002098597 (1:201954696 G>A)
Disease associations
OMIM: gene MIM:605057 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
54 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | affects cotreatment, increases abundance, increases oxidation, decreases expression | 3 |
| Valproic Acid | affects expression, decreases methylation, increases expression | 3 |
| Smoke | decreases expression, increases abundance | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| Cadmium Chloride | increases abundance, increases expression | 2 |
| Particulate Matter | increases abundance, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| alpha-pinene | increases oxidation, increases abundance, affects cotreatment | 1 |
| bisphenol A | decreases expression | 1 |
| nobiletin | decreases expression, decreases reaction | 1 |
| sodium arsenate | decreases expression, decreases reaction | 1 |
| O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | affects expression, affects response to substance | 1 |
| arsenite | decreases expression, increases degradation, increases expression, affects binding, decreases reaction | 1 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| 1,10-phenanthroline | decreases reaction, decreases expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| methacrylaldehyde | affects cotreatment, increases oxidation, increases abundance | 1 |
| tamibarotene | affects expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Acrolein | increases oxidation, increases abundance, affects cotreatment | 1 |
| Adenosine Triphosphate | decreases expression, decreases reaction | 1 |
| Amiodarone | increases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Vehicle Emissions | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3J8 | Abcam HEK293T TIMM17A KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.